SEC
SlamSEC
SearchBrowseEarnings

BIO-TECHNE Corp

Nasdaq:TECH
Biological Products, (No Diagnostic Substances)·MINNEAPOLIS, MN
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(1000 total)

TypeDateAccessionPeriodSize
4
Mar 4, 2026
0000914190-26-000036STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Mar 2, 2026
27.2 KB
3
Mar 4, 2026
0000914190-26-000035INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Mar 1, 2026
20.0 KB
4
Feb 19, 2026
0000914190-26-000030STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Feb 17, 2026
25.3 KB
144
Feb 17, 2026
0001950047-26-001315
—
4.6 KB
8-K
Feb 11, 2026
0001104659-26-0134128-K
Feb 9, 2026
331.3 KB
4
Feb 5, 2026
0000914190-26-000011STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Feb 3, 2026
27.0 KB
10-Q
Feb 4, 2026
0001104659-26-01033510-Q
Dec 31, 2025
11.4 MB
8-K
Feb 4, 2026
0001104659-26-0099948-K
Feb 4, 2026
806.4 KB
4
Feb 3, 2026
0000914190-26-000009STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Feb 1, 2026
20.0 KB
SCHEDULE 13G/A
Nov 14, 2025
0000080255-25-000801
—
7.5 KB
4
Nov 5, 2025
0000914190-25-000031STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Nov 3, 2025
26.5 KB
4
Nov 5, 2025
0000914190-25-000030STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Nov 3, 2025
28.4 KB
4
Nov 5, 2025
0000914190-25-000029STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Nov 3, 2025
22.6 KB
10-Q
Nov 5, 2025
0001104659-25-10705310-Q
Sep 30, 2025
9.1 MB
8-K
Nov 5, 2025
0001104659-25-1066318-K
Oct 30, 2025
633.5 KB
4
Nov 3, 2025
0000914190-25-000025STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Oct 30, 2025
13.7 KB
4
Nov 3, 2025
0000914190-25-000024STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Oct 30, 2025
16.1 KB
4
Nov 3, 2025
0000914190-25-000021STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Oct 30, 2025
17.3 KB
4
Nov 3, 2025
0000914190-25-000020STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Oct 30, 2025
13.7 KB
4
Nov 3, 2025
0000914190-25-000019STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Oct 30, 2025
25.5 KB
4
Nov 3, 2025
0000914190-25-000018STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Oct 30, 2025
9.0 KB
4
Nov 3, 2025
0000914190-25-000017STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Oct 30, 2025
15.0 KB
4
Nov 3, 2025
0000914190-25-000016STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Oct 30, 2025
17.3 KB
ARS
Sep 19, 2025
0001308179-25-000601ANNUAL REPORT TO SECURITY HOLDERS
Jun 30, 2025
2.2 MB
DEFA14A
Sep 19, 2025
0001308179-25-000600DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
—
4.8 MB
25 filings shown

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

CEO
Kelderman Kim
CFO
Hippel James